Newsroom

Obésité et trisomie 21 : des avancées annoncées par deux laboratoires bordelais

Dec 2, 2021

15h Biotech Express

Dec 2, 2021

YSOPIA Bioscience Announces First Signs of Biological Activity from Phase I Analysis of Xla1, its...

Dec 2, 2021

Eposter / Safety Evaluation of Christensenella minuta as a Novel Microbiome-based Biotherapy to Treat...

Nov 1, 2021

YSOPIA Bioscience Announces Leadership Team Reorganization and Appoints Co-Founder & CFO Fabrice...

Nov 1, 2021

EMA & FDA Apply a Similar Mindset When Providing Scientific Advice For Live Biotherapeutic...

Sep 13, 2021